@article{fdi:010077413,
  title = {{T}he {WHO} strategy for prevention and control of snakebite envenoming : a sub-{S}aharan {A}frica plan},
  author = {{C}hippaux, {J}ean-{P}hilippe and {M}assougbodji, {A}. and {H}abib, {A}. {G}.},
  editor = {},
  language = {{ENG}},
  abstract = {{S}nakebite is a critical public health issue in tropical countries, particularly in {A}frica, where 20% of snakebites globally occur. {I}n 2017, the {WHO} added snakebite envenoming to the category {A} of neglected tropical diseases. {I}n 2019, thanks to broad institutional and international {NGO} support, including strong mobilization of {A}frican experts and governments, {WHO} launched a strategy for prevention and control of snakebite envenoming with more ambitious goals. {I}n sub-{S}aharan {A}frica, accessibility of antivenoms and symptomatic, adjuvant or replacement therapy is a priority. {S}everal antivenoms are available but their evaluation has not been properly carried out and they remain expensive. {T}o date, there are no manufacturers of antivenom in sub-{S}aharan {A}frica (except in {S}outh {A}frica), which requires their importation from other continents. {T}he lack of experience in antivenom choice and its use by health authorities, health personnel and population largely explains the shortage in sub-{S}aharan {A}frica. {T}he deficiency of epidemiological data does not allow the implementation of appropriate and efficient care. {I}t is crucial to strengthen the health system which does not have the necessary means for emergency management in general and envenoming in particular. {P}roviding peripheral health centers with antivenoms would decrease complications and deaths. {T}he motivation of communities at risk, identified through the epidemiological data, would be to reduce the delay in consultation that is detrimental to the efficiency of treatment. {P}artnerships need to be coordinated to optimize resources from international institutions, particularly {A}frican ones, and share the burden of treatment costs among all stakeholders. {W}e propose here a project of progressive implementation of antivenom manufacturing in sub-{S}aharan {A}frica. {T}he various steps, from the supply of appropriate venoms to the production of purified specific antibodies and vial filling, would be financed by international, regional and local funding promoting technology transfer from current manufacturers compensated by interest on the sale of antivenoms.},
  keywords = {{S}nakebite ; {E}nvenomation ; {A}ntivenom ; {S}ub-{S}aharan {A}frica ; {N}eglected tropical diseases ; {C}ontrol ; {AFRIQUE} {SUBSAHARIENNE}},
  booktitle = {},
  journal = {{J}ournal of {V}enomous {A}nimals and {T}oxins {I}ncluding {T}ropical {D}iseases},
  volume = {25},
  numero = {},
  pages = {e20190083 [6 p.]},
  year = {2019},
  DOI = {10.1590/1678-9199-jvatitd-2019-0083},
  URL = {https://www.documentation.ird.fr/hor/fdi:010077413},
}